Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base — a European multicentre mixed methods study
Constantinos J Stefanidis,
Valentin Ritschl,
Rukshana Shroff,
Fabian Eibensteiner,
Tanja Stamm,
Asil Cetin,
Claus Peter Schmitt,
Gema Ariceta,
Sevcan Bakkaloglu,
Augustina Jankauskiene,
Günter Klaus,
Fabio Paglialonga,
Alberto Edefonti,
Bruno Ranchin,
Johan Vandewalle,
Enrico Verrina,
Karel Vondrak,
Aleksandra Zurowska,
Seth L Alper,
Christoph Aufricht
Affiliations
Constantinos J Stefanidis
Department of Pediatric Nephrology, Mitera Children’s Hospital, Athens, Greece
Valentin Ritschl
Center for Medical Data Science, Institute for Outcomes Research, Medical University of Vienna, Wien, Austria
Rukshana Shroff
Renal Unit, UCL Great Ormond Street Hospital for Children NHS Foundation Trust and Institute of Child Health, London, UK
Fabian Eibensteiner
3 Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Wien, Austria
Tanja Stamm
Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria
Asil Cetin
Research Platform Data Science, University of Vienna, Vienna, Austria
Claus Peter Schmitt
Pediatric Nephrology, Center for Child and Adolescent Medicine, Heidelberg University, Heidelberg, Germany
Gema Ariceta
Department of Pediatric Nephrology, University Hospital Vall d`Hebron, Barcelona, Spain
Sevcan Bakkaloglu
Division of Pediatric Nephrology, Gazi University Faculty of Medicine, Ankara, Turkey
Augustina Jankauskiene
Pediatric Center, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
Günter Klaus
Department of Pediatric Nephrology, KfH Children’s Kidney Center, Marburg, Germany
Fabio Paglialonga
Pediatric Nephrology, Dialysis and Transplant Unit, La Fondazione IRCCS Ca` Granda Ospedale Maggiore di Milano Policlinico, Milano, Italy
Alberto Edefonti
Pediatric Nephrology, Dialysis and Transplant Unit, La Fondazione IRCCS Ca` Granda Ospedale Maggiore di Milano Policlinico, Milano, Italy
Bruno Ranchin
Department of Pediatric Nephrology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France
Johan Vandewalle
Department of Pediatric Nephrology, Utoped, Universitair Ziekenhuis Gent, Ghent, Belgium
Enrico Verrina
Division of Nephrology, Dialysis and Transplantation, Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova, Italy
Karel Vondrak
Department of Pediatric Nephrology, University Hospital Motol, Prague, Czech Republic
Aleksandra Zurowska
Department of Pediatric Nephrology, Medical University of Gdansk, Gdansk, Poland
Seth L Alper
Division of Nephrology and Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Christoph Aufricht
3 Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Wien, Austria
Objectives In a previously published Delphi exercise the European Pediatric Dialysis Working Group (EPDWG) reported widely variable counteractive responses to COVID-19 during the first week of statutory public curfews in 12 European countries with case loads of 4–680 infected patients per million. To better understand these wide variations, we assessed different factors affecting countermeasure implementation rates and applied the capability, opportunity, motivation model of behaviour to describe their determinants.Design We undertook this international mixed methods study of increased depth and breadth to obtain more complete data and to better understand the resulting complex evidence.Setting This study was conducted in 14 paediatric nephrology centres across 12 European countries during the COVID-19 pandemic.Participants The 14 participants were paediatric nephrologists and EPDWG members from 12 European centres.Main outcome measures 52 countermeasures clustered into eight response domains (access control, patient testing, personnel testing, personal protective equipment policy, patient cohorting, personnel cohorting, suspension of routine care, remote work) were categorised by implementation status, drivers (expert opinion, hospital regulations) and resource dependency. Governmental strictness and media attitude were independently assessed for each country and correlated with relevant countermeasure implementation factors.Results Implementation rates varied widely among response domains (median 49.5%, range 20%–71%) and centres (median 46%, range 31%–62%). Case loads were insufficient to explain response rate variability. Increasing case loads resulted in shifts from expert opinion-based to hospital regulation-based decisions to implement additional countermeasures despite increased resource dependency. Higher governmental strictness and positive media attitude towards countermeasure implementation were associated with higher implementation rates.Conclusions COVID-19 countermeasure implementation by paediatric tertiary care centres did not reflect case loads but rather reflected heterogeneity of local rules and of perceived resources. These data highlight the need of ongoing reassessment of current practices, facilitating rapid change in ‘institutional behavior’ in response to emerging evidence of countermeasure efficacy.